Valerenic Acid
APC-997
Valerenic Acid
Cat. No.
APC-997
CAS No.
3569-10-6
MF
C15H22O2
MW
234.33
Valerenic Acid, a sesquiterpenoid, is an positive allosteric modulator of GABAA receptors.
Technical Service Need help? Our team of experienced experts is here for you with full support.
86-28-85159085
info@aktin.com
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
3569-10-6
MF
C15H22O2
MW
234.33
Specification
98%
Research Area
Anxiolytic and antioxidant
Description
Valerenic Acid, a sesquiterpenoid, is an positive allosteric modulator of GABAA receptors. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Documents
Certificate of Analysis (COA), Specification Sheet, HPLC, 1HNMR, 13CNMR, IR, MS, Safety Data Sheet (SDS/MSDS) etc.
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat.
References
[1]. Benke D, et, al. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology. 2009 Jan;56(1):174-81.
[2]. Dietz BM, et, al. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 2005 Aug 18;138(2):191-7.
[3]. Kara M, et, al. Ameliorative Effects of the Sesquiterpenoid Valerenic Acid on Oxidative Stress Induced in HepG2 Cells after Exposure to the Fungicide Benomyl. Antioxidants (Basel). 2021 May 8;10(5):746.
[4]. Becker A, et, al. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement Altern Med. 2014 Jul 28;14:267.
[2]. Dietz BM, et, al. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 2005 Aug 18;138(2):191-7.
[3]. Kara M, et, al. Ameliorative Effects of the Sesquiterpenoid Valerenic Acid on Oxidative Stress Induced in HepG2 Cells after Exposure to the Fungicide Benomyl. Antioxidants (Basel). 2021 May 8;10(5):746.
[4]. Becker A, et, al. The anxiolytic effects of a Valerian extract is based on valerenic acid. BMC Complement Altern Med. 2014 Jul 28;14:267.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
APC-1828
Eritadenine
CAS No.: 23918-98-1
MF: C9H11N5O4
APC-1827
Isobutyrylshikonin
CAS No.:52438-12-7
MF:C20H22O6
APC-1823
SO1861 (C28 sugar-chain positional isomer)
CAS No.:N/A
MF:C83H129O46
APC-1822
Bromocriptine mesylate
CAS No.:22260-51-1
MF:C32H40BrN5O5.CH4O3S
APC-1821
Cephaeline hydrochloride
CAS No.:3738-70-3
MF:C28H38N2O4.ClH
APC-1820
8-Feruloylharpagide
CAS No.:221003-20-9
MF:C25H32O13
APC-1819
6''-O-(p-coumaroyl)procumbide
CAS No.:87686-76-8
MF:C24H28O12
APC-1818
6′′-O-(p-Coumaroyl)harpagide
CAS No.:133561-42-9
MF:C24H30O12
APC-1817
Falcarinol
CAS No.:21852-80-2
MF:C17H24O
APC-1816
Dehydrotomatine
CAS No.:157604-98-3
MF:C50H81NO21
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.
